Rationale: Cardiac progenitor cells (CPCs) in the adult heart are used for cell-based treatment of myocardial damage, but factors determining stemness, self-renewal, and lineage commitment are poorly understood. Immortal DNA strands inherited through asymmetric chromatid segregation correlate with self-renewal of adult stem cells, but the capacity of CPCs for asymmetric segregation to retain immortal strands is unknown. Cardioprotective kinase Pim-1 increases asymmetric cell division in vivo, but the ability of Pim-1 to enhance asymmetric chromatid segregation is unknown.
T he immortal strand hypothesis states that adult stem cells selectively retain chromatids with old DNA strands (the mother strand), whereas all differentiating progeny acquire the newly synthesized daughter to protect stem cells from DNA replication errors 1 and aging. 2 The silent sister hypothesis presumes template strand segregation of all or some chromatids to regulate gene expression to determine cell fate. 3, 4 The immortal strand and silent sister hypotheses are supported by observations of absolute to partial asymmetric chromatid segregation (ACS) in adult stem cells like mouse intestinal and colon epithelial stem cells, 5, 6 neural stem cells, 7 satellite cells 8, 9 and many cancer stem cells. 10, 11 Stem cells also may undergo symmetric segregation on an intermittent basis and switch back to asymmetric segregation. 7, 8, 10, 11 The silent sister hypothesis also is supported by the correlation of ACS with asymmetric cell division, self-renewal, and fate determination. [7] [8] [9] [10] Discovery of resident adult stem cells specific to the heart, termed cardiac progenitor cells (CPCs), 12 have opened new possibilities for cell-based treatment of heart disease that could be mitigated by improved myocardial regeneration. 13 CPCs found in cardiac niches are c-kitpositive, clonogenic, multipotent, self-renewing, and capable of asymmetrical division. 12, 14 Results of a phase I clinical trial with CPCs are promising, 15 but clinical potential of CPCs is limited by donor age and disease state. 16, 17 CPCs in aged myocardium are senescent, with limited replication potential. 17 Therefore, a subset of CPCs capable of ACS would be desirable to preserve youthful self-renewal of the stem cell phenotype. ACS in CPCs is enhanced two-fold in our study by overexpression of Pim-1, a kinase that enhances cardiac repair, 18 increases asymmetric cell division, 19 and promotes CPC self-renewal.
Editorial, see p 1154

Methods
Cell culture, treatments, BrdU immunostaining, and image quantification are described in the detailed Methods provided in the Online Supplement. Experimental design for label release and retention assay are explained and depicted in Online Figure I .
Label Release Assay
"Immortal" strands are never labeled, as per the initial postulate of Cairns. 1 Short-time BrdU labeling for a single S-phase results in CPCs with one labeled and one unlabeled DNA strand (Online Figure IA) . After completion of mitosis when cells are chased in BrdU free media, chromatids with unlabeled stands segregate from chromatids with newly made BrdU-labeled strands. Therefore, stem cells release the label because of retention of the oldest immortal strands not being labeled throughout the assay. 7, 11 
Label Retention Assay
Long-term BrdU exposure of CPCs allows for labeling of both DNA strands (Online Figure IB) , assuming switching occurs between symmetric and asymmetric segregation as previously published. 6 -8,10,11 After completion of a single mitotic division, chasing cells in BrdU free medium results in CPCs with one labeled and one unlabeled strand in a chromatid. After a second round of mitosis, labeled immortal strands will segregate from the unlabeled new strands; therefore, label retention will occur for CPCs continuing to asymmetrically segregate their chromatids. 6, 7, 10 
Results
Cell-cycle distribution of CPCs after drug-induced mitotic synchronization of the cell population is shown in Online Figure II . Use of a label release assay (Online Figure IA ) was devised to demonstrate presence of unlabeled "immortal stands." Asymmetric segregation of unlabeled immortal strands from BrdU-labeled newly synthesized strands is revealed by rare binucleated CPCs with one daughter nucleus having little or no BrdU staining, whereas the other nucleus is positive for BrdU ( Figure 1A ). CPCs exhibiting daughter nuclei with equal BrdU intensity indicate symmetrical segregation ( Figure 1B) .
Label retention assay (Online Figure IB) validates results of the release assay that is limited to CPCs undergoing DNA synthesis at the time of labeling. Both strands are BrdUlabeled in the label retention assay, in which CPCs are continuously labeled and passaged at least four times to dilute slowly cycling and exclusively asymmetrically segregating CPCs. 6 -8,10 Daughter nuclei with approximately 50:50 BrdU intensity ratio (only symmetric segregation) are observed in CPCs blocked at first mitosis during chase ( . CPCs never exhibited a completely negative paired with positive BrdU daughter nuclei pair, consistent with previous reports of punctate BrdU staining. 10, 20 Therefore, ACS is defined as a daughter nuclei pair having BrdU ratio of Ն70:30, similar to chromosome in situ hybridization experiment, 5 instead of absolute ratio (100:0), confirming that not all chromatids are asymmetrically segregated. 4, 21, 22 CPCs with asymmetric segregation of chromatids with BrdU intensity ratio of Ն70:30 between the daughter nuclei are found in 4.59% of the population (nϭ4; 53-194 binucleated cells per experiment). CPCs during late stage mitosis collected through mitotic shake-off exhibit asymmetric ( Figure 3A ) and symmetric BrdU intensity ( Figure 3B ), demonstrating that ACS occurs without requiring druginduced cell-cycle arrest. Intensity differences between daughter nuclei are not attributable to differences in focal plane, as confirmed by confocal optical sectioning ( Figure  3C ), validating asymmetrical segregation of BrdU-labeled chromatids.
CPCs overexpressing Pim-1 and enhanced green fluorescent protein (CPCeP) or enhanced green fluorescent protein alone (CPCe) were used to test the capacity of Pim-1 to 
Discussion
Autologous cell therapy with CPC is an efficacious treatment for heart failure. 15 Beneficial effects of naïve cells are improved by modification and selection to promote reparative potential in the harsh milieu of a postinfarct heart. 16 Modification with Pim-1 facilitates CPC survival and proliferation after infarction injury, 18, 23 in addition to numerous other signaling molecules and pathways that facilitate stem cellmediated repair. 16 However, CPC-mediated regeneration could be further augmented by identification of a cell subset that possesses enhanced potential for self-renewal as evidenced by ACS. Therefore, there is a need to identify signal transduction cascades that enhance ACS to confer superior self-renewal properties. The presence of immortal/template strands and ACS in adult stem cells remains controversial. [2] [3] [4] The immortal strand hypothesis assumes ability of stem cells to retain old strands to minimize transformational risk associated with DNA replication errors. 1 Our findings of predominant rather than total ACS are consistent with direct observation of chromatid segregation 5 and punctate BrdU retention in nonmyocardial stem cell studies, 10, 20 indicating partial ACS might be specific to stem cell type. The silent sister hypothesis presumes ACS to regulate differential gene expression profile to determine cell fate and self-renewal, 3, 4, 24 which is strengthened by the observation of cosegregation of template strands with self-renewal markers in stem cells 7-10 and of conformational changes in histone variant H2A.Z on template strands. 20 Functional significance of ACS through study of live cells is technically challenging because of protocols of fixation and immunolabeling required for detection by fluorescent cell sorting to isolate asymmetrically segregating cells, although utilization of directly labeled thymidine analogues recently has been used in cancer stem cells to circumvent fixation requirements. 25, 26 Future studies will capitalize on the functional characterization of asymmetrically segregating CPCs to determine their regenerative potential relative to comparable CPCs undergoing symmetric segregation, with the expectation that asymmetric segregation correlates with enhanced myocardial repair.
Previous research in our laboratory established multiple beneficial roles for Pim-1, including enhancement of proliferation, survival, and commitment of CPCs without causing tumor formation after transplantation. 18, 19 Pim-1-mediated increase in ACS can be explained by the multifaceted participation of Pim-1 in mitosis and transcriptional regulation. Pim-1 colocalizes at spindle poles during mitosis to phosphorylate NuMA and promote complex formation with HP1␤, dynein, and dynactin during chromosome segregation. 27 The left-right dynein motor is necessary for selective segregation of mouse chromosome 7. 22 Pim-1 also binds and phosphorylates HP1␥ on serine-rich clusters, modulating its transcriptional repression activity. 28 Pim-1-mediated phosphorylation of HP1 proteins, which are involved in chromatin structure, indicates that Pim-1 likely modulates chromatin dynamics. Chromatin dynamic regulation by Pim-1 could explain the functional significance of ACS in conjunction with the silent sister hypothesis and stem cell self-renewal. Pim-1 increases asymmetrically dividing CPCs in the heart after pathological injury to balance self-renewing versus differentiated cell populations. 19 Pim-1 decreases spontaneous differentiation of embryonic stem cells 29 and is highly expressed in long-term populating hematopoietic stem cells, 30 supporting the premise that Pim-1 regulates stemness. Future studies are warranted to address the direct role of Pim-1 in ACS and stem cell self-renewal to further enhance the regenerative potential of CPCs and other stem cell types. 
Novelty and Significance
What Is Known?
• Preferential partitioning of old versus newly synthesized DNA strands known as asymmetric segregation is hypothesized to regulate self-renewal and aging in several cell types.
• The cardioprotective kinase Pim-1 increases proliferation, asymmetric cell division, and regenerative potential of cardiac progenitor cells (CPCs).
What New Information Does This Article Contribute?
• Asymmetric partitioning of old versus newly synthesized DNA formed during mitosis occurs in a small subpopulation of CPCs.
• Asymmetric segregation of chromatids into daughter CPCs is enhanced by Pim-1 kinase overexpression.
CPCs are potentially effective as agents of cell-based regenerative treatment for myocardial damage. However, factors that determine self-renewal and lineage commitment of CPCs are poorly understood. The regenerative potential of aged CPCs may be compromised in elderly patients with chronic heart disease. Identification and characterization of subsets of CPCs that exhibit preservation of proliferative potential and enhanced self-renewal might be valuable for use in the clinical setting to augment stem cell-based repair. Superior self-renewal properties and protection from phenotypic characteristics of aging are associated with asymmetric chromatid segregation wherein old DNA strands preferentially distribute to a single daughter cell during mitosis. This study confirms that asymmetric DNA segregation occurs in CPCs at a low frequency consistent with rates observed for other adult stem cell types. Moreover, the frequency of asymmetric DNA segregation in CPCs can be significantly increased by overexpression of Pim-1 kinase. The observation of increased asymmetric segregation with Pim-1 overexpression may help explain the enhanced regenerative properties of CPCs engineered to overexpress Pim-1 and provide another mechanistic basis for increasing self-renewal of CPCs that might be essential for effective myocardial repair.
